These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
338 related items for PubMed ID: 22193845
1. Molecular imaging of amyloidosis: will the heart be the next target after the brain? Chen W, Dilsizian V. Curr Cardiol Rep; 2012 Apr; 14(2):226-33. PubMed ID: 22193845 [Abstract] [Full Text] [Related]
2. Non-invasive detection and differentiation of cardiac amyloidosis using 99mTc-pyrophosphate scintigraphy and 11C-Pittsburgh compound B PET imaging. Takasone K, Katoh N, Takahashi Y, Abe R, Ezawa N, Yoshinaga T, Yanagisawa S, Yazaki M, Oguchi K, Koyama J, Sekijima Y. Amyloid; 2020 Dec; 27(4):266-274. PubMed ID: 32722948 [Abstract] [Full Text] [Related]
3. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis. Hutt DF, Quigley AM, Page J, Hall ML, Burniston M, Gopaul D, Lane T, Whelan CJ, Lachmann HJ, Gillmore JD, Hawkins PN, Wechalekar AD. Eur Heart J Cardiovasc Imaging; 2014 Nov; 15(11):1289-98. PubMed ID: 24939945 [Abstract] [Full Text] [Related]
5. Amyloidosis of heart and liver: comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate for detection. Lee VW, Caldarone AG, Falk RH, Rubinow A, Cohen AS. Radiology; 1983 Jul; 148(1):239-42. PubMed ID: 6304810 [Abstract] [Full Text] [Related]
6. Clinical Phenotyping of Transthyretin Cardiac Amyloidosis with Bone-Seeking Radiotracers in Heart Failure with Preserved Ejection Fraction. Chen W, Ton VK, Dilsizian V. Curr Cardiol Rep; 2018 Mar 08; 20(4):23. PubMed ID: 29520480 [Abstract] [Full Text] [Related]
7. Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques. Aljaroudi WA, Desai MY, Tang WH, Phelan D, Cerqueira MD, Jaber WA. J Nucl Cardiol; 2014 Apr 08; 21(2):271-83. PubMed ID: 24347127 [Abstract] [Full Text] [Related]
8. [Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation]. Hongo M, Yamada H, Okubo S, Hirayama J, Fujii T, Kusama S, Ikeda S. J Cardiogr; 1985 Mar 08; 15(1):163-80. PubMed ID: 2999267 [Abstract] [Full Text] [Related]
9. 99mTc Bone-Avid Tracer Cardiac Scintigraphy: Role in Noninvasive Diagnosis of Transthyretin Cardiac Amyloidosis. Khor YM, Cuddy SAM, Singh V, Falk RH, Di Carli MF, Dorbala S. Radiology; 2023 Feb 08; 306(2):e221082. PubMed ID: 36537896 [Abstract] [Full Text] [Related]
14. Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis. Galat A, Rosso J, Guellich A, Van Der Gucht A, Rappeneau S, Bodez D, Guendouz S, Tissot CM, Hittinger L, Dubois-Randé JL, Plante-Bordeneuve V, Itti E, Meignan M, Damy T. Amyloid; 2015 Jul 08; 22(4):210-20. PubMed ID: 26465835 [Abstract] [Full Text] [Related]
15. Role of cardiac scintigraphy with ⁹⁹mTc-DPD in the differentiation of cardiac amyloidosis subtype. de Haro-del Moral FJ, Sánchez-Lajusticia A, Gómez-Bueno M, García-Pavía P, Salas-Antón C, Segovia-Cubero J. Rev Esp Cardiol (Engl Ed); 2012 May 08; 65(5):440-6. PubMed ID: 22464102 [Abstract] [Full Text] [Related]
16. Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate: A Test in Evolution. Poterucha TJ, Elias P, Bokhari S, Einstein AJ, DeLuca A, Kinkhabwala M, Johnson LL, Flaherty KR, Saith SE, Griffin JM, Perotte A, Maurer MS. JACC Cardiovasc Imaging; 2021 Jun 08; 14(6):1221-1231. PubMed ID: 33221204 [Abstract] [Full Text] [Related]